What is hypernatremia, including its pathophysiology, etiology, clinical manifestations, diagnostic approach, treatment, and recent advances?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypernatremia: Comprehensive Overview for Provider Theory Examination

Definition and Classification

Hypernatremia is defined as a plasma sodium concentration greater than 145 mmol/L, representing a disorder of water balance where there is either absolute or relative water deficit compared to sodium content. 1, 2

Classification Systems

By Duration:

  • Acute hypernatremia: <24-48 hours duration, allowing for rapid correction without significant neurological risk 1, 3
  • Chronic hypernatremia: >48 hours duration, requiring slow correction (maximum 10-15 mmol/L per 24 hours or 0.4 mmol/L/hour) to prevent cerebral edema, seizures, and neurological injury 4, 1, 3

By Severity:

  • Mild: 146-149 mmol/L 1
  • Moderate: 150-159 mmol/L 1
  • Severe/Threatening: ≥160 mmol/L 1

By Volume Status and Pathogenesis:

  • Hypervolemic hypernatremia: Excess total body sodium with relatively less water excess 1, 2
  • Euvolemic hypernatremia: Normal total body sodium with water deficit 1, 2
  • Hypovolemic hypernatremia: Deficit of both water and sodium, with proportionally greater water loss 1, 2, 5

Pathophysiology and Biochemistry

Normal Water Homeostasis

Total body water and tonicity are tightly regulated through four integrated mechanisms: 6

  1. Antidiuretic hormone (ADH/vasopressin): Released from the posterior pituitary in response to increased plasma osmolality (>295 mOsm/kg) or decreased effective circulating volume, promoting water reabsorption in the collecting ducts 6

  2. Renin-angiotensin-aldosterone system (RAAS): Regulates sodium reabsorption and indirectly affects water balance 6

  3. Thirst mechanism: Stimulated at plasma osmolality >295 mOsm/kg, providing behavioral drive for water intake 6

  4. Norepinephrine: Contributes to volume regulation 6

Mechanisms of Hypernatremia Development

Hypernatremia fundamentally reflects an imbalance where water loss exceeds sodium loss, or sodium gain exceeds water gain. 1, 5 The disorder rarely results from excessive sodium intake alone but rather from:

  • Impaired access to water: Patients with altered mental status, mechanical ventilation, physical restraints, or institutionalization cannot respond to thirst 2, 6
  • Impaired thirst mechanism: Hypothalamic lesions, advanced age, or osmoreceptor dysfunction 2, 6
  • Excessive water losses: Renal or extrarenal routes exceeding intake 2, 5
  • Iatrogenic causes: Hypertonic saline administration, sodium bicarbonate infusions, or inadequate free water provision 1, 2

Cellular Consequences

Acute hypernatremia causes cellular dehydration through osmotic water shift from intracellular to extracellular compartments, particularly affecting brain cells. 1 This leads to:

  • Brain cell shrinkage and potential vascular rupture
  • Risk of intracerebral and subarachnoid hemorrhage
  • Central nervous system dysfunction 1, 3

Chronic hypernatremia triggers adaptive mechanisms: Brain cells generate organic osmolytes (idiogenic osmoles) including taurine, glutamine, and myoinositol to restore cell volume over 24-48 hours. 1 This adaptation explains why rapid correction of chronic hypernatremia is dangerous—it creates a relative hypotonic state causing cerebral edema. 4, 3

Etiology

Hypervolemic Hypernatremia (Sodium Excess)

Acute causes:

  • Hypertonic saline (3% NaCl) administration 1
  • Sodium bicarbonate infusions 1
  • Salt poisoning or ingestion 1

Chronic causes:

  • Primary hyperaldosteronism (Conn's syndrome) 1
  • Cushing's syndrome 1

Euvolemic Hypernatremia (Pure Water Deficit)

Central (Neurogenic) Diabetes Insipidus:

  • Traumatic: Head injury, neurosurgery 1
  • Vascular: Subarachnoid hemorrhage, Sheehan syndrome 1
  • Infectious: Meningitis, encephalitis 1
  • Neoplastic: Craniopharyngioma, metastases 1
  • Infiltrative: Sarcoidosis, histiocytosis X 1
  • Idiopathic: Autoimmune destruction 1

Nephrogenic Diabetes Insipidus:

  • Pharmacological: Lithium (most common), demeclocycline, foscarnet, amphotericin B 1
  • Metabolic: Hypokalemia, hypercalcemia 1
  • Congenital: AVPR2 or AQP2 gene mutations 7
  • Chronic kidney disease: Medullary damage 1

Insensible water losses:

  • Fever (increases by ~10% per degree Celsius above 37°C) 2
  • Tachypnea 2
  • Burns 2

Hypovolemic Hypernatremia (Water Loss > Sodium Loss)

Renal losses (urine sodium typically >20 mmol/L):

  • Osmotic diuresis (hyperglycemia, mannitol, urea) 2, 5
  • Loop diuretics 2, 5
  • Post-obstructive diuresis 2
  • Intrinsic renal disease 2

Extrarenal losses (urine sodium typically <20 mmol/L):

  • Gastrointestinal: Diarrhea, vomiting (particularly in infants and elderly) 2, 5
  • Cutaneous: Excessive sweating, burns 2, 5
  • Respiratory: Hyperventilation 2

Clinical Manifestations

Central Nervous System Symptoms (Predominant)

The clinical presentation is primarily characterized by CNS dysfunction due to brain cell dehydration: 3

  • Altered mental status: Confusion, lethargy, obtundation progressing to coma 3, 2
  • Seizures: Particularly in severe or rapidly developing hypernatremia 4, 3
  • Focal neurological deficits: May mimic stroke 2
  • Irritability and restlessness: Especially in children 2
  • Muscle weakness and hyperreflexia: From cellular dysfunction 2

Thirst and Volume Status

  • Intense thirst (polydipsia): Present in conscious patients with intact thirst mechanism 3, 2
  • Volume depletion signs (in hypovolemic hypernatremia): Orthostatic hypotension, tachycardia, dry mucous membranes, decreased skin turgor, sunken eyes 2
  • Volume overload signs (in hypervolemic hypernatremia): Edema, hypertension, jugular venous distension 2

Severe Complications

  • Intracerebral hemorrhage: From vascular rupture due to brain shrinkage 1
  • Subarachnoid hemorrhage: Particularly in acute severe hypernatremia 1
  • Rhabdomyolysis: From severe cellular dehydration 2
  • Increased mortality: Hypernatremia is associated with significantly increased hospital mortality 6

Diagnostic Approach

Eight-Step Diagnostic Algorithm 2

Step 1: Exclude Pseudohypernatremia

  • Rule out laboratory error or severe hyperlipidemia/hyperproteinemia (rare with modern ion-selective electrodes) 2

Step 2: Confirm Glucose-Corrected Sodium

  • Correct for hyperglycemia: Add 1.6 mmol/L to measured sodium for every 100 mg/dL (5.6 mmol/L) glucose above 100 mg/dL 2
  • This distinguishes true hypernatremia from translocational hyponatremia 2

Step 3: Determine Extracellular Volume Status

  • Hypovolemic: Orthostatic hypotension, tachycardia, dry mucous membranes, decreased skin turgor, flat neck veins 2
  • Euvolemic: Normal blood pressure, no edema, normal jugular venous pressure 2
  • Hypervolemic: Edema, hypertension, elevated jugular venous pressure 2

Step 4: Measure Urine Sodium Levels

  • Urine Na+ <20 mmol/L: Suggests extrarenal losses (GI, skin, respiratory) 2
  • Urine Na+ >20 mmol/L: Suggests renal losses or sodium excess 2

Step 5: Measure Urine Volume and Osmolality

  • Urine osmolality >800 mOsm/kg: Appropriate renal response to hypernatremia; suggests extrarenal losses or sodium excess 2
  • Urine osmolality <300 mOsm/kg: Inappropriate dilute urine; suggests diabetes insipidus 2
  • Polyuria (>3 L/day): Strongly suggests diabetes insipidus 7, 2

Step 6: Check Ongoing Urinary Electrolyte-Free Water Clearance

  • Calculate free water clearance to quantify ongoing losses 2
  • Formula: CH₂O = Urine volume × [1 - (Urine Na + Urine K)/Plasma Na] 2

Step 7: Determine Arginine Vasopressin/Copeptin Levels

  • Low/undetectable copeptin with polyuria: Central diabetes insipidus 2
  • Elevated copeptin with polyuria: Nephrogenic diabetes insipidus 2
  • Note: Copeptin is a stable surrogate marker for ADH 2

Step 8: Assess Other Electrolyte Disorders

  • Hypokalemia: Can cause nephrogenic diabetes insipidus 1, 2
  • Hypercalcemia: Can cause nephrogenic diabetes insipidus 1, 2

Key Laboratory Tests

Essential initial workup:

  • Serum sodium, potassium, chloride, bicarbonate 2
  • Blood urea nitrogen and creatinine 2
  • Serum glucose 2
  • Serum osmolality 2
  • Urine osmolality and sodium 2
  • Urine volume (24-hour or timed collection) 2

Additional tests based on clinical suspicion:

  • Serum calcium and potassium (if diabetes insipidus suspected) 2
  • Copeptin or ADH levels (if diabetes insipidus suspected) 2
  • Brain imaging (if central diabetes insipidus suspected) 1

Water Deprivation Test (for Diabetes Insipidus Diagnosis)

Indications: Polyuria with inappropriately dilute urine 7

Procedure:

  • Withhold fluids under close supervision 7
  • Monitor weight, vital signs, serum and urine osmolality hourly 7
  • Central DI: Urine osmolality remains <300 mOsm/kg; increases >50% after desmopressin administration 7
  • Nephrogenic DI: Urine osmolality remains <300 mOsm/kg; minimal response (<10% increase) to desmopressin 7
  • Primary polydipsia: Urine osmolality increases appropriately (>600 mOsm/kg) with dehydration 7

Treatment

Six-Step Management Algorithm 2

Step 1: Identify and Treat Underlying Causes

  • Discontinue offending medications: Lithium, diuretics 1, 2
  • Treat diabetes insipidus: Desmopressin for central DI 7, 3
  • Correct electrolyte abnormalities: Hypokalemia, hypercalcemia 1, 2
  • Restore access to water: For patients with impaired access 2
  • Treat infections or other precipitants: Address underlying pathology 2

Step 2: Distinguish Acute from Chronic Hypernatremia

This is the most critical decision point determining correction rate: 4, 1, 3

  • Acute (<24-48 hours): Rapid correction is safe and prevents cellular dehydration complications; can correct at 1 mmol/L/hour 1, 3
  • Chronic (>48 hours) or unknown duration: Slow correction mandatory (maximum 10-15 mmol/L per 24 hours or 0.4 mmol/L/hour) to prevent cerebral edema 4, 1, 3

Step 3: Calculate Water Deficit and Determine Rate

Water deficit formula: 2

  • Water deficit (L) = Total body water × [(Current Na/140) - 1]
  • Total body water = 0.6 × body weight (kg) in men; 0.5 × body weight (kg) in women

Correction rate guidelines:

  • Acute hypernatremia: Can correct rapidly, up to 1 mmol/L/hour 1, 3
  • Chronic hypernatremia: Maximum 10-15 mmol/L per 24 hours (0.4-0.6 mmol/L/hour) 4, 1, 3
  • Conservative approach: Target 8-10 mmol/L per 24 hours for chronic cases 3

Step 4: Select Type of Replacement Solution

For hypervolemic hypernatremia:

  • Avoid hypotonic fluids initially 2
  • Loop diuretics (furosemide) to promote sodium excretion 2
  • Then hypotonic fluids (0.45% NaCl or D5W) once euvolemic 2

For euvolemic hypernatremia:

  • Hypotonic fluids: 0.45% NaCl (half-normal saline) or D5W (5% dextrose in water) 2
  • D5W preferred if no glucose intolerance 2
  • Oral water if patient can tolerate (safest route) 2

For hypovolemic hypernatremia:

  • Initial resuscitation: 0.9% normal saline to restore hemodynamic stability 2, 5
  • Then switch to hypotonic fluids (0.45% NaCl or D5W) once hemodynamically stable 2, 5

Special consideration for nephrogenic diabetes insipidus:

  • Avoid isotonic saline (0.9% NaCl): The tonicity (300 mOsm/kg) exceeds typical urine osmolality in NDI (100 mOsm/kg) by 3-fold, requiring ~3 L urine to excrete the osmotic load from 1 L isotonic fluid, risking serious hypernatremia 7
  • Use 5% dextrose with no renal osmotic load 7
  • Calculate maintenance rate: Children: first 10 kg at 100 mL/kg/24h; 10-20 kg at 50 mL/kg/24h; remaining at 20 mL/kg/24h; Adults: 25-30 mL/kg/24h 7

Step 5: Account for Ongoing Losses

Add to calculated deficit: 2

  • Insensible losses: ~500-1000 mL/day (increases with fever, tachypnea) 2
  • Ongoing urine losses: Measure and replace, especially in diabetes insipidus 2
  • GI losses: If diarrhea or vomiting present 2

Step 6: Adjust Treatment Schedule with Frequent Monitoring

Monitoring frequency:

  • Severe hypernatremia (>160 mmol/L): Check serum sodium every 2-4 hours initially 2
  • Moderate hypernatremia: Check every 4-6 hours 2
  • Mild hypernatremia: Check every 6-12 hours 2

Adjust infusion rate based on actual sodium change versus target 2

Specific Treatment for Diabetes Insipidus

Central Diabetes Insipidus:

  • Desmopressin (DDAVP): 1-4 mcg subcutaneous/IV or 10-20 mcg intranasal twice daily 7, 3
  • Titrate to control polyuria while avoiding hyponatremia 7

Nephrogenic Diabetes Insipidus (Congenital):

Dietary management: 7

  • Low sodium intake (≤6 g/day): Reduces osmotic load and urine volume 7
  • Low protein diet (<1 g/kg/day): Reduces urea-mediated osmotic diuresis 7
  • Dietetic counseling essential 7

Pharmacological therapy: 7

  • Thiazide diuretics (hydrochlorothiazide): Impair urinary dilution in distal tubule, enhance proximal water reabsorption via volume depletion; efficacy may decrease with age 7
  • Amiloride: Impairs urinary dilution in collecting duct; used in combination with thiazides, particularly for lithium-induced NDI 7
  • Prostaglandin synthesis inhibitors: Enhance collecting duct water permeability; risk of GI ulcers 7
  • Celecoxib (selective COX-2 inhibitor): Reduces GI bleeding risk compared to non-selective COX inhibitors 7

Emergency management of hypernatremic dehydration in NDI:

  • Avoid salt-containing solutions (0.9% NaCl): Will worsen hypernatremia due to high osmotic load relative to dilute urine 7
  • Use 5% dextrose at maintenance rate 7
  • Low threshold for IV rehydration if oral failed 7

Hemodialysis for Severe Acute Hypernatremia

Indications: 3

  • Acute hypernatremia (<24 hours) with severe elevation (>160-170 mmol/L) 3
  • Hypernatremia with acute kidney injury requiring dialysis 3
  • Allows rapid, controlled correction 3

Caution: When starting renal replacement therapy in chronic hypernatremia, use dialysate with higher sodium concentration to avoid rapid sodium drop 3

Recent Advances and Evidence

Copeptin as Diagnostic Biomarker

Copeptin (C-terminal pro-vasopressin) is a stable surrogate marker for ADH that can be measured reliably, unlike ADH itself. 2 This represents a significant diagnostic advance:

  • Low copeptin with polyuria: Confirms central diabetes insipidus 2
  • High copeptin with polyuria: Confirms nephrogenic diabetes insipidus 2
  • May replace water deprivation test in many cases 2

Congenital Nephrogenic Diabetes Insipidus Management

The 2025 international expert consensus statement provides comprehensive management guidelines for congenital NDI: 7

  • Combination therapy with thiazides, amiloride, and COX-2 inhibitors more effective than monotherapy 7
  • Importance of low sodium and protein diet emphasized 7
  • Surveillance imaging (renal ultrasound every 2 years) to detect hydronephrosis from voluntary urine retention 7
  • Recognition of CKD risk in NDI patients requiring closer monitoring 7

Correction Rate Controversies

Recent evidence emphasizes the critical importance of distinguishing acute from chronic hypernatremia: 4, 1, 3

  • Acute hypernatremia: Rapid correction is safe and beneficial, preventing cellular dehydration complications 1, 3
  • Chronic hypernatremia: Slow correction (10-15 mmol/L per 24 hours maximum) is mandatory to prevent cerebral edema 4, 1, 3
  • When duration unknown: Treat as chronic to err on side of safety 4, 3

Mortality and Morbidity Data

Hypernatremia is associated with increased morbidity and mortality, making prompt treatment essential: 6, 5

  • Hospital-acquired hypernatremia carries worse prognosis than community-acquired 5
  • Both undercorrection and overcorrection associated with poor outcomes 4
  • Frequent monitoring essential to optimize correction rate 4, 2

Common Pitfalls and How to Avoid Them

Pitfall 1: Too rapid correction of chronic hypernatremia

  • Consequence: Cerebral edema, seizures, neurological injury, death 4, 3
  • Avoidance: Always assume chronic if duration unknown; limit correction to 10-15 mmol/L per 24 hours; check sodium every 2-4 hours initially 4, 3, 2

Pitfall 2: Using isotonic saline in nephrogenic diabetes insipidus

  • Consequence: Worsening hypernatremia due to high osmotic load relative to dilute urine 7
  • Avoidance: Use 5% dextrose or hypotonic solutions in NDI 7

Pitfall 3: Inadequate monitoring during correction

  • Consequence: Overcorrection or undercorrection 4, 2
  • Avoidance: Check sodium every 2-4 hours in severe cases; adjust infusion rate based on actual response 2

Pitfall 4: Failing to account for ongoing losses

  • Consequence: Persistent hypernatremia despite calculated replacement 2
  • Avoidance: Add insensible losses (~500-1000 mL/day) and ongoing measured losses to calculated deficit 2

Pitfall 5: Using hypotonic fluids before volume resuscitation in hypovolemic hypernatremia

  • Consequence: Hemodynamic instability, inadequate tissue perfusion 2, 5
  • Avoidance: Restore hemodynamic stability with isotonic saline first, then switch to hypotonic fluids 2, 5

Pitfall 6: Not correcting hyperglycemia-induced pseudohypernatremia

  • Consequence: Misdiagnosis and inappropriate treatment 2
  • Avoidance: Always correct sodium for glucose: add 1.6 mmol/L per 100 mg/dL glucose above 100 mg/dL 2

Pitfall 7: Ignoring underlying cause

  • Consequence: Recurrent hypernatremia, treatment failure 2
  • Avoidance: Always identify and treat underlying etiology (discontinue lithium, treat diabetes insipidus, restore water access) 1, 2

References

Research

Diagnostic and therapeutic approach to hypernatremia.

Diagnosis (Berlin, Germany), 2022

Research

Evaluation and management of hypernatremia in adults: clinical perspectives.

The Korean journal of internal medicine, 2023

Research

[Hypernatremia - Diagnostics and therapy].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2016

Guideline

Hypernatremia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Salt and Water: A Review of Hypernatremia.

Advances in kidney disease and health, 2023

Research

Hyponatremia and hypernatremia: disorders of water balance.

The Journal of the Association of Physicians of India, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.